Metabolomic analysis of serum may refine 21-gene expression assay risk recurrence stratification

Despite recent refinements to the 21-gene g score, allowing a better identification of patients who may derive no benefit from the addition of adjuvant chemotherapy to that of endocrine therapy, patients with early breast cancer still stand to be over-treated in the setting of clinical and/or genomi...

Descripción completa

Detalles Bibliográficos
Autores principales: McCartney, Amelia, Vignoli, Alessia, Tenori, Leonardo, Fornier, Monica, Rossi, Lorenzo, Risi, Emanuela, Luchinat, Claudio, Biganzoli, Laura, Di Leo, Angelo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715716/
https://www.ncbi.nlm.nih.gov/pubmed/31482106
http://dx.doi.org/10.1038/s41523-019-0123-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715716/
https://www.ncbi.nlm.nih.gov/pubmed/31482106
http://dx.doi.org/10.1038/s41523-019-0123-9

Ejemplares similares